To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy? [electronic resource]
Producer: 20050628Description: 392-400 p. digitalISSN:- 1053-2498
- Adult
- Aged
- Antilymphocyte Serum -- therapeutic use
- Decision Making
- Follow-Up Studies
- Graft Rejection -- drug therapy
- HLA Antigens -- immunology
- Heart Transplantation
- Humans
- Immunosuppression Therapy -- methods
- Immunosuppressive Agents -- therapeutic use
- Middle Aged
- Multivariate Analysis
- Muromonab-CD3 -- therapeutic use
- North America -- epidemiology
- Perioperative Care -- methods
- Retrospective Studies
- Risk Factors
- Severity of Illness Index
- Survival Rate -- trends
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.